StonvexLoading…
StonvexStonvexStonvexCore line items from HIMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.35B | $1.48B | $872.00M | $526.92M |
Operating Income | $105.61M | $61.90M | $-29.45M | $-68.70M |
Net Income | $128.37M | $126.04M | $-23.55M | $-65.68M |
EPS (Diluted) | $0.51 | $0.53 | $-0.11 | $-0.32 |
Total Assets | $2.15B | $707.54M | $441.19M | $366.34M |
Total Liabilities | $1.61B | $230.82M | $97.16M | $54.60M |
Cash & Equivalents | $228.62M | $220.58M | $96.66M | $46.77M |
Free Cash Flow OCF − CapEx | $57.41M | $198.28M | $46.98M | $-33.73M |
Shares Outstanding | 258.23M | 236.81M | 209.34M | 204.52M |